Home
About
Overview
Sharing Data
ORCID
Help
History (43)
Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancer.
Biomarkers in lung cancer: from early detection to novel therapeutics and decision making.
Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling.
Complete response to chemoimmunotherapy with bevacizumab in synchronous multiple primary cancers: pulmonary adenocarcinoma and sarcomatoid carcinoma.
The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer.
See All 43 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer.
The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer. Trends Cancer. 2018 02; 4(2):110-118.
View in:
PubMed
subject areas
Animals
Drug Resistance, Neoplasm
Epigenesis, Genetic
Humans
Neoplasms
authors with profiles
Ravi Salgia